Answers are grounded in this paper and cite their sources.
In recent years, industry has reduced its investment in U.S. biomedical research and development by billions of dollars, while increasing investment in Asia–Oceania. Thus, boosting U.S. government funding alone may be inadequate for retaining long-term R&D leadership.
No takes yet. Share an insight, caveat, or question.
Chakma et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: